INVUS OPPORTUNITIES
Invus Opportunities is a sister fund to The Invus Group, an equity investment firm founded in 1985 with over $8 billion of evergreen capital. Invus Opportunities is focused on partnering with market-leading management teams and investors in private transactions globally. With a differentiated heritage and capital base, Invus Opportunities brings a complementary dimension to growing companies and investor groups seeking to create lasting value. Invus Opportunities both leads rounds of financing and co-invests in syndicated financings, and currently manages over $1.5 billion.
INVUS OPPORTUNITIES
Status:
Active
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-07 | SpringWorks Therapeutics | Invus Opportunities investment in Post-IPO Equity - SpringWorks Therapeutics | 225 M USD |
| 2022-06-13 | Ablative Solutions | Invus Opportunities investment in Series D - Ablative Solutions | 91.4 M USD |
| 2022-05-25 | Booster | Invus Opportunities investment in Series D - Booster | 125 M USD |
| 2022-01-24 | Klarity | Invus Opportunities investment in Series A - Klarity | 18 M USD |
| 2022-01-14 | Bolt | Invus Opportunities investment in Series E - Bolt | 355 M USD |
| 2021-06-25 | ClearScore | Invus Opportunities investment in Private Equity Round - ClearScore | 200 M USD |
| 2021-04-20 | RippleMatch | Invus Opportunities investment in Venture Round - RippleMatch | 23.5 M USD |
| 2021-04-15 | Zenflow | Invus Opportunities investment in Series B - Zenflow | 24.37 M USD |
| 2021-02-18 | Descomplica | Invus Opportunities investment in Series E - Descomplica | 450 M BRL |
| 2020-01-11 | PACT Pharma | Invus Opportunities investment in Series C - PACT Pharma | 75 M USD |